Venetoclax combined with decitabine and HAAG regimen: a novel salvage strategy for relapsed/refractory T-cell acute lymphoblastic leukaemia. Zhu Y, Dai Y, Tang X. Ann Hematol 2022;101:2525-2528.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhu Y, Dai Y, Tang X. Venetoclax combined with decitabine and HAAG regimen: a novel salvage strategy for relapsed/refractory T-cell acute lymphoblastic leukaemia. Ann Hematol 2022;101:2525-2528.
PMID: 36063200